SNDX - Syndax Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SNDX is currently covered by 11 analysts with an average price target of $37.08. This is a potential upside of $13.6 (57.92%) from yesterday's end of day stock price of $23.48.

Syndax Pharmaceuticals's activity chart (see below) currently has 67 price targets and 80 ratings on display. The stock rating distribution of SNDX is 97.56% BUY and 2.44% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 28.29% with an average time for these price targets to be met of 228.53 days.

Highest price target for SNDX is $43, Lowest price target is $23, average price target is $37.08.

Most recent stock forecast was given by BRADLEY CANINO from STIFEL on 26-Jun-2024. First documented stock forecast 31-Mar-2016.

Currently out of the existing stock ratings of SNDX, 40 are a BUY (97.56%), 1 are a HOLD (2.44%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

42

$18.52 (78.88%)

40

19 days ago

0/4 (0%)

$22.12 (111.27%)

Buy

41

$17.52 (74.62%)

41

28 days ago

6/21 (28.57%)

$21.12 (106.24%)

606

Buy

34

$10.52 (44.80%)

38

1 months 24 days ago

0/5 (0%)

$13.34 (64.57%)

Buy

30

$6.52 (27.77%)

35

2 months 6 days ago

3/7 (42.86%)

$8.03 (36.55%)

355

Hold

23

$-0.48 (-2.04%)

36

5 months 14 days ago

1/3 (33.33%)

$2.51 (12.25%)

23

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SNDX (Syndax Pharmaceuticals) average time for price targets to be met?

On average it took 228.53 days on average for the stock forecasts to be realized with a an average price target met ratio 28.29

Which analyst has the current highest performing score on SNDX (Syndax Pharmaceuticals) with a proven track record?

MADHU KUMAR

Which analyst has the most public recommendations on SNDX (Syndax Pharmaceuticals)?

Madhu Kumar works at GOLDMAN SACHS and has 8 price targets and 5 ratings on SNDX

Which analyst is the currently most bullish on SNDX (Syndax Pharmaceuticals)?

Konstantinos Aprilakis with highest potential upside - $20.49

Which analyst is the currently most reserved on SNDX (Syndax Pharmaceuticals)?

David Lebowitz with lowest potential downside - -$2.48

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?